MIR3164

Across TCGA pan-cancer cohorts, MIR3164 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MIR3164’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR3164 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3164 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

HNSC, KIRC, and LIHC are the cancer types where MIR3164 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3164 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.387	.002	7	view →
KIRC	Male	All	+0.453	<.001	5	view →
LIHC	All	All	+0.262	.002	5	view →
BLCA	All	All	+0.595	.028	4	view →
LUSC	Male	III,IV	+1.364	.007	3	view →
CHOL	All	All	+1.341	.004	2	view →
STAD	Male	IV	−1.040	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MIR3164–HNSC

Open the HNSC breakdown →